A Phenotypic and Mechanistic Perspective on Heterogeneity of HER2-positive Breast Cancers

Molecular and Cellular Oncology - United Kingdom
doi 10.1080/23723556.2016.1232186
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Identification of New miRNA Biomarkers Associated With HER2-positive Breast Cancers

Oncoscience
Cancer ResearchOncology
2015English

ZW25 Active in HER2-positive Cancers

Cancer Discovery
Oncology
2018English

Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers

Oncologist
Cancer ResearchMedicineOncology
2017English

Intrinsic Molecular Subtypes of Breast Cancers Categorized as HER2-positive Using an Alternative Chromosome 17 Probe Assay

Breast Cancer Research
Cancer ResearchOncology
2018English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Optimal Treatment of Early Stage HER2-positive Breast Cancer

Cancer
Cancer ResearchOncology
2018English

Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers

Cancer Research
Cancer ResearchOncology
2016English

Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival

British Journal of Cancer
Cancer ResearchOncology
2012English

Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers Treated With Neoadjuvant Chemotherapy

Targeted Oncology
Cancer ResearchOncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy